Recommended Treatment for Depression
For patients with major depressive disorder, either cognitive behavioral therapy (CBT) or second-generation antidepressants are strongly recommended as first-line treatments after discussing treatment effects, adverse effect profiles, cost, accessibility, and preferences with the patient. 1
First-Line Treatment Options
Psychotherapy
- Cognitive Behavioral Therapy (CBT) is a strongly recommended first-line treatment with moderate-quality evidence supporting its efficacy 1
- Benefits include:
- No medication-related side effects
- Provides skills that may prevent future episodes
- May be preferred by patients concerned about medication side effects
Pharmacotherapy
- Second-generation antidepressants (SGAs) are equally strongly recommended as first-line treatment 1
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
- Selective Serotonin Norepinephrine Reuptake Inhibitors (SSNRIs)
Medication Selection and Dosing
SSRIs (Most commonly prescribed)
Sertraline (Zoloft)
Fluoxetine (Prozac)
Escitalopram (Lexapro)
- Starting dose: 10 mg daily
- Maximum dose: 20 mg daily
- Advantages: More favorable side effect profile among SSRIs 3
SNRIs
Venlafaxine
- Has an ascending dose-response curve (unlike SSRIs)
- Low doses act primarily on serotonin, higher doses affect norepinephrine 6
- Monitor blood pressure at higher doses
Duloxetine
- More balanced serotonin and norepinephrine reuptake inhibition
- Useful for patients with comorbid pain conditions 6
Treatment Course and Monitoring
Acute Phase (6-12 weeks)
- Evaluate response after 1-2 weeks of treatment initiation 3
- Adjust medication based on response and tolerability
- Monitor for side effects, particularly in the first weeks
Continuation Phase (4-9 months)
- Continue treatment to prevent relapse
- Maintain effective dose
Maintenance Phase (≥1 year)
- For recurrent depression, maintain treatment for at least 1 year 3
- For first episode, treatment should continue for at least 4-9 months after achieving remission
Important Monitoring Considerations
Side Effects
- Approximately 63% of patients experience at least one adverse effect from SSRIs 3
- Common side effects include:
- Nausea, diarrhea
- Insomnia, anxiety
- Sexual dysfunction
- Headache, dizziness
- Weight changes
Special Precautions
Suicidality Risk
- Monitor closely, especially in young adults (18-24)
- Risk is highest in initial weeks of treatment 4
Bipolar Disorder Screening
Discontinuation
- Taper medication gradually to avoid discontinuation syndrome
- Do not abruptly stop treatment
Second-Step Treatments
If first-line treatment is ineffective or poorly tolerated:
- Switch to a different antidepressant class
- Augment with another medication
- Switch to or add psychotherapy
- Different switching and augmentation strategies provide similar symptomatic relief 1
Common Pitfalls to Avoid
- Failing to screen for bipolar disorder before starting antidepressants
- Not monitoring for suicidal thoughts, particularly in young adults
- Discontinuing medication too soon after symptom improvement
- Overlooking medication interactions (e.g., risk of serotonin syndrome)
- Not recognizing that full therapeutic effect may take 4-5 weeks or longer